Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
CSL ( (AU:CSL) ) has issued an announcement.
CSL Limited announced the lapse of 19,884 conditional rights to securities, effective January 10, 2025, due to certain conditions not being met. This cessation of securities may impact the company’s capital management strategies and could influence stakeholder perceptions regarding the company’s financial maneuvers.
More about CSL
CSL Limited operates in the biotechnology industry and specializes in the development and delivery of innovative medicines and therapies. The company focuses on providing solutions in areas such as immunology, hematology, and respiratory care.
YTD Price Performance: 0.14%
Average Trading Volume: 563
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $84.81B
See more data about CSL stock on TipRanks’ Stock Analysis page.